Geranium herb plus hormone therapy for early prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether adding a herbal extract from geranium to standard hormone therapy can improve outcomes before surgery for prostate cancer that has spread only a little. It is for men who have not had any previous prostate cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old
- You have prostate cancer confirmed by biopsy (not a rare small-cell type)
- Your cancer has spread to no more than 5 spots (in bones or lymph nodes) or is stage T3-4 (locally advanced)
- You have a good performance status (ECOG 0-1) meaning you can do most daily activities without help
- You have not received any previous treatment for prostate cancer (like radiation, chemotherapy, or hormone therapy)
- You agree to have surgery (radical prostatectomy) after the study treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of a chemotherapy drug (homoharringtonine) and hormone therapy (androgen deprivation) given before surgery to shrink prostate cancer that has spread a little or is advanced. The goal is to see if this approach can help control the cancer better before the prostate is removed.
This trial tests a new combination of drugs (Fasudil, a PD1 inhibitor, and hormone therapy) before prostate cancer surgery to see if it works better than standard treatment. It's for patients with early metastatic or locally advanced prostate cancer who haven't had any prior treatment.
This trial tests two oral hormone drugs (darolutamide and relugolix) given before prostate removal surgery for men with high-risk prostate cancer. The goal is to see if this combination shrinks the tumor and improves treatment outcomes.
This trial studies giving hormone treatment and radiation before prostate surgery to treat high-risk, locally advanced prostate cancer. It aims to improve cancer control by shrinking or controlling the tumor before removing it.
This trial tests whether adding a drug called homoharringtonine (a type of chemotherapy) to standard hormone therapy before prostate surgery can improve outcomes for men with certain stages of prostate cancer. It's for men who haven't had any previous treatment and plan to have their prostate removed.
This trial tests whether removing the prostate (surgery) plus standard hormone therapy and chemotherapy can help men whose prostate cancer has spread to many places in the body. It is for men who have not yet had treatment for their cancer.
Hear when a new Prostate CA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.